Neelakantan Murali, Sharma Parth, Kulkarni Ashish
Principal Lawyer, Amicus, India.
Association for Socially Applicable Research (ASAR), Pune, Maharashtra, India.
Lancet Reg Health Southeast Asia. 2024 May 16;26:100425. doi: 10.1016/j.lansea.2024.100425. eCollection 2024 Jul.
Poor drug regulation in India is not a recent problem. The Indian drug market is full of look-alike, sound-alike (LASA) drugs which have not yet caught the attention of the media or the medical community. This viewpoint highlights the problem of LASA drugs and poor prescription practices and proposes solutions for involving all stakeholders in this unaddressed issue which is a huge public health problem in India.
印度药品监管不力并非近期才出现的问题。印度药品市场充斥着外观相似、名称相似（LASA）的药品，这些药品尚未引起媒体或医学界的关注。这一观点突出了LASA药品问题以及不良处方行为，并针对让所有利益相关者参与解决这一在印度是重大公共卫生问题的未得到解决的问题提出了解决方案。
